Correction
==========

In the course of type-setting this article \[[@B1]\] for final publication the presentation of the data in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} was altered. To avoid any confusion and to improve the clarity of our results the corrected Tables are included here.

###### 

Demographic and disease characteristics of patients who underwent full baseline assessment

                                                         **All subjects**                              
  ------------------------ ------------- --------------- ------------------ ------------- ------------ ------
                                         **Mean (SD)**                                                 
  **Age**                  (yrs)                         67.9 (9.4)         67.6 (10.9)   68.4 (6.3)   0.88
  **Body mass index**      (kg/m^2^)                     23.1 (4.6)         23.7(4.9)     22.1(4.2)    0.52
                                         **N (%)**                                                     
  **Sex**                                                                                              
                           M                             9 (60)             4 (40)        5 (100)       
                           F                             6 (40)             6 (60)        0 (0)        0.04
  **PS**                                                                                               
                           1                             2 (13)             2 (20)        0 (0)         
                           2                             6 (40)             4 (40)        2 (40)        
                           3                             7 (47)             4 (40)        3 (60)       0.79
  **Diagnosis**                                                                                        
                           Lung Cancer                   4 (27)             3 (30)        1 (20)        
                           GI cancer                     6 (40)             2 (20)        4 (80)        
                           Other                         5 (33)             5 (50)        0 (0)        NA
  **Cancer stage**                                                                                     
                           III                           1 (7)              1 (10)        0 (0)         
                           IV                            11 (73)            6 (60)        5 (100)       
                           NA                            3 (20)             3 (30)        0 (0)        NA
  **Chemotherapy**                                                                                     
                           Y                             10 (67)            6 (60)        4 (80)        
                           N                             5 (33)             4 (40)        1 (20)       0.60
  **Recent steroid use**                                                                               
                           Y                             6 (40)             4 (40)        2 (40)        
                           N                             9 (60)             6 (60)        3 (60)       1.00

Notes: P indicates result of significance testing (unpaired *t*-test for means or Fisher's exact test for count data) comparing patients who did, or did not complete the study.

###### 

Physical performance evaluation results at baseline and after 6 weeks of NMES intervention

             **Baseline**    **End of study**                                                                                   
  ---------- --------------- ------------------ ------------- ------------ ------------ ---------- ------------ --------------- ----------
             **Number**                                                                                                         
  **PS**     1                                                0            2            0.79^\#^   4                            0.15^\#^
             2                                                2            4                       4                             
             3                                                3            4                       2                             
             **Mean (SD)**                                                                                                      
  **6MWT**   m                                  257(160)      166 (138)    303 (157)    0.11       282 (171)    −21.1 (167.7)   0.70
             \%                                 50.2 (32.2)   31.0(24.6)   59.8(32.2)   0.08       56.0(34.5)   −3.8 (33.3)     0.73
  **STS**    s                                  8.0(4.3)      7.6 (3.4)    8.2 (4.8)    0.80       7.0(3.3)     −1.2 (3.4)      0.30
             S-score                            2.6(2.4)      2.2 (2.0)    2.7 (2.2)    0.69       2.0(1.8)     −0.7 (2.0)      0.30

Notes: Performance status (PS), six-minute walk distance (6MWT) in metres (m) and expressed as % predicted (from \[21\]), Sit-to-stand (STS) test expressed as seconds (s) and as a standard score (S-score) value calculated using age range-specific mean and standard deviations for healthy controls (from \[22\]): positive scores indicates STS S-scores above the mean. P^a:\ \#^Fisher's exact (for counts) or unpaired *t*-test (for means) comparing baseline results for patients withdrawn and patients who completed study. P^b:\ \#^Fisher's exact (for counts) or paired *t*-test (for means) comparing baseline and final test results for patients who completed the study.
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